Research Paper Volume 13, Issue 13 pp 17847—17863

Prognostic value of fatty acid metabolism-related genes in patients with hepatocellular carcinoma

The validation of the risk prognostic model in HCC patients. (A–D) t-SNE, PCA, survival status scatter plots and risk score distribution shown the power prognostic ability of the risk prognostic model in TCGA. (E–H) t-SNE, PCA, survival status scatter plots and risk score distribution shown the power prognostic ability of the risk prognostic model in ICGC.

Figure 5. The validation of the risk prognostic model in HCC patients. (AD) t-SNE, PCA, survival status scatter plots and risk score distribution shown the power prognostic ability of the risk prognostic model in TCGA. (EH) t-SNE, PCA, survival status scatter plots and risk score distribution shown the power prognostic ability of the risk prognostic model in ICGC.